US Patent 7888314 Compositions and methods for treating peripheral vascular disease
Patent 7888314 was granted and assigned to Amylin Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+193 characters)
Article
Patent abstract
The present invention relates to methods of treating intermittent claudication comprising administering glucagon-like peptide-1 (GLP-1) molecules to subjects suffering therefrom.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
David R. Hathaway0
Thomas R. Coolidge0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07888314 Compositions and methods for treating peripheral vascular disease US Patent 7888314 Compositions and methods for treating peripheral vascular disease
Infobox
Patent Number
078883140
Patent Number
78883140
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078883140
Date of Patent
February 15, 2011
0Patent Application Number
111985270
Date Filed
August 5, 2005
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07888314 Compositions and methods for treating peripheral vascular disease
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07888314
Date of patent
February 15, 2011
Patent application number
11198527
Date Filed
August 5, 2005
Patent primary examiner
Find more entities like US Patent 7888314 Compositions and methods for treating peripheral vascular disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
